India Pharmaceutical Consulting

India’s pharmaceutical market is worth more than $13 billion and is projected to grow between 10% and 15% over the next five years. With strong economic development, India’s consumption of pharmaceuticals is increasing rapidly. It is important for international companies to understand India’s evolving healthcare environment to do well in its drug market. PBM has worked on a wide range of India pharmaceutical consulting projects. We have helped many international pharmaceutical companies in finding distributors, sourcing APIs and conducting market research in India.

With India’s growing economy, lifestyle changes are changing the country’s disease profile. As Indians become wealthier, they are eating more unhealthy foods, smoking more, and leading less active lifestyles. This leads to greater incidence of lifestyle-related diseases such as diabetes, cardiovascular disease and cancer. Other conditions including HIV, mental illnesses and dermatological diseases have rising incidence and high pharmaceutical sales potential.

About 97% of India’s pharmaceutical market value is made up of generic substances. The pharmaceutical market in India is highly fragmented with at least 10,000 drug manufacturers. Only a fraction of these manufacturers are large-scale. These local drug manufacturers are just beginning to spend more on research and development (R&D).

Currently, pharmaceutical manufacturing by international companies is growing India through subsidiaries, joint ventures, or contract manufacturers. International companies are increasingly making use of India’s low labor costs and are improving the quality of their manufacturing base. International companies who wish to expand their pharmaceutical operations into India can approach PBM’s pharmaceutical consultants for assistance and professional guidance.

On the regulatory front, India’s Drugs and Cosmetics Act (DCA) governs the registration, import, manufacture, testing, and sale of drugs and cosmetics. One area the DCA does not cover is drug advertising. This is regulated by a separate law, the Drugs & Magic Remedies (Objectionable Advertisements) Act of 1954.

PBM’s India pharmaceutical consultants are goal-oriented professionals who dedicate their efforts to help international companies succeed. PBM consultants leverage their vast experience and knowledge of the pharmaceutical industry to ensure clients’ business goals are achieved in India’s drug market.

For inquiries on PBM’s India pharmaceutical consultant services, please contact us or view PBM’s publications to gain more insight into the Indian pharmaceutical market.